OptiNose, Inc.
NASDAQ: OPTN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ramy A. Mahmoud
- Employees
- 127
- Headquarters
- Yardley, United States
- IPO year
- 2017
- Market cap
- $97.2M
- Website
- https://www.optinose.com
Loading OPTN…
Loading profile data…Frequently asked questions about OPTN
What does OptiNose, Inc. (OPTN) do?
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topic...
Where does OPTN trade?
OptiNose, Inc. (OPTN) trades on the NASDAQ Global Select.
What sector is OPTN in?
OptiNose, Inc. (OPTN) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of OptiNose, Inc.?
Ramy A. Mahmoud is the chief executive officer of OptiNose, Inc. (OPTN).
Where is OptiNose, Inc. headquartered?
OptiNose, Inc. is headquartered in United States.
Does OPTN pay a dividend?
OptiNose, Inc. (OPTN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OPTN go public?
OptiNose, Inc. (OPTN) completed its initial public offering in 2017.